Combination antiglaucoma formulation for pets Opthovet-DT combines Dorzolamide Hydrochloride (2%) and Timolol Maleate (0.5%) to effectively lower intraocular pressure (IOP) by reducing aqueous humor production. Suitable for primary and secondary glaucoma, it is also useful for long-term management and prevention of disease progression.
Composition
Dorzolamide Hydrochloride – 2%
Timolol Maleate – 0.5%
Indications / Uses
Primary or secondary glaucoma
Ocular hypertension
Adjunct therapy in chronic glaucoma management
Pre- and post-surgical IOP control
Prevention of progression in at-risk patients
Key Benefits
Dual-action mechanism for enhanced IOP reduction
Suitable for routine and maintenance therapy
Helps preserve vision by preventing optic nerve damage
